Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

The Key to Stopping Sarcomas’ Spread

By Drug Discovery Trends Editor | May 13, 2015

Poul Sorensen. Source: BC Cancer FoundationWhen sarcomas become large enough and outgrow their blood supply, they become vulnerable to hypoxia — a lack of oxygen. That adaptation not only enables them to survive the stress of low oxygen — it also enables them to withstand cancer drugs.

Poul Sorensen, a Professor in the Department of Pathology & Laboratory Medicine and Johal Chair in Childhood Cancer Research, has found a previously unrecognized pathway that allows those sarcomas to withstand the stress of hypoxia or cancer drugs.

His research, published May 11 in Cancer Cell, describes how a protein called YB-1, which is highly expressed across virtually all human sarcoma subtypes, can directly stimulate the production of another protein, HIF1a, which makes tumor cells stress-resistant and thus more invasive.

Sarcomas are tumors of the connective tissues, including bones and muscles. They are more common in children and can be extremely difficult to treat because they have a high tendency to metastasize, or spread. There has been little progress in treating the condition for the past two decades, in part because its metastatic mechanism has eluded scientists.

“This process appears to be specific for tumor cells, which could have profound implications for targeting the YB-1-HIF1α pathway therapeutically,” said Dr. Sorensen, a Distinguished Scientist at the BC Cancer Agency, who conducted the research with Amal El-Naggar, a post-doctoral fellow.

By blocking the production of HIF1a through the YB-1 pathway, Dr. Sorensen and Dr. El-Naggar found that local tumors more susceptible to low oxygen conditions, dramatically inhibiting the spread of childhood sarcoma cells to the lungs. With this knowledge, researchers are now trying to find a drug that would target this pathway.

There may also be therapeutic applications for other cancers. The data suggests that this pathway is also active in adult epithelial cancers such as breast cancer.

There are 12 cases of sarcoma per year in B.C., and approximately 30-40 per cent of patients die of their disease, particularly in high-risk disease.

Source: UBC


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE